I. Holme

W. März, I. Holme, H. Scharnagl, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study

O. Faergeman, I. Holme, J. Kastelein, 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study.

O. Faergeman, I. Holme, J. Kastelein, 2004, The American journal of cardiology.

Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis.

I. Holme, 1993, British heart journal.

Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men.

I. Holme, A. Tverdal, P. Leren, 1989, American journal of epidemiology.

A prospective cohort study of depression in pregnancy, prevalence and risk factors in a multi-ethnic population

I. Holme, A. K. Jenum, E. Martinsen, 2015, BMC Pregnancy and Childbirth.

Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals

I. Holme, H. Arnesen, I. Seljeflot, 2001, Journal of Clinical Microbiology.

Combined modality treatment of operated astrocytomas grade 3–4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy

Jensen, J. Haase, R. Hatlevoll, 1984 .

Femoral Lesion Change in Relation to Measured Risk Factors in the Stockholm-Uppsala Trial

I. Holme, A. Olsson, U. Erikson, 1990 .

A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension.

I. Holme, I. Hjermann, P. Hjortdahl, 2009, Acta medica Scandinavica.

Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study.

I. Holme, I. Hjermann, L. Håheim, 1996, Journal of epidemiology and community health.

Correlates of systolic and diastolic blood pressure in men 40 to 59 years of age sampled from United States of America and Union of Soviet Socialist Republics Lipid Research Clinics populations.

I. Holme, J. Abernathy, A. Deev, 1988, American Journal of Cardiology.

Survival in elderly men in relation to midlife and current BMI.

S. Tonstad, I. Holme, 2015, Age and ageing.

On‐treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study

D. Waters, I. Holme, J. Kastelein, 2011, European journal of clinical investigation.

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, Journal of internal medicine.

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow‐up periods in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, G. Walldius, 2008, Journal of internal medicine.

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.

I. Holme, D. Demicco, C. Wun, 2012, Arthritis and rheumatism.

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial.

I. Holme, A. Semb, T. Kvien, 2011, Rheumatology.

Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.

I. Holme, K. Egstrup, T. Pedersen, 2010, The American journal of cardiology.

Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.

I. Holme, A. Jardine, H. Holdaas, 2009, Arthritis and rheumatism.

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

C. Furberg, I. Holme, A. Aastveit, 2007, The American journal of cardiology.

Effect of greater LDL-C reductions on prognosis-the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

O. Faergeman, I. Holme, A. Olsson, 1999 .

Uric acid and clinical correlates of endothelial function in kidney transplant recipients

I. Holme, A. Åsberg, A. Hartmann, 2014, Clinical transplantation.

The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12‐year follow‐up of the Oslo Study, Norway

I. Holme, I. Hjermann, L. Håheim, 1993, Journal of internal medicine.

The effect on HDL cholesterol of oxprenolol and atenolol.

I. Holme, S. Kjeldsen, P. Leren, 1982, Scandinavian journal of clinical and laboratory investigation.

Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.

S. Nilsson, I. Holme, G. Walldius, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Drug treatment of mild hypertension to reduce the risk of CHD: is it worth-while?

I. Holme, 1988, Statistics in medicine.

HDL-cholesterol in antihypertensive treatment. The Oslo Study.

I. Holme, I. Hjermann, S. Enger, 2009, Acta medica Scandinavica. Supplementum.

The effect of dietary changes on high density lipoprotein cholesterol. The Oslo Study.

I. Holme, I. Hjermann, S. Enger, 1979, The American journal of medicine.

Prediction of Cardiovascular Events in Patients with Ankylosing Spondylitis and Psoriatic Arthritis: Role of Lipoproteins in a High-risk Population

I. Holme, D. Demicco, C. Wun, 2012, The Journal of Rheumatology.

Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein.

I. Holme, G. Walldius, K. Hådell, 1994, Atherosclerosis.

Probucol treatment decreases serum concentrations of diet-derived antioxidants.

I. Holme, G. Walldius, L. Elinder, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females

I. Holme, G. Walldius, I. Jungner, 1992, International journal of clinical & laboratory research.

EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1980, The Lancet.

Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study

L. Solberg, J. Strong, I. Holme, 1980 .

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.

H. Prydz, I. Holme, I. Hjermann, 1989, Arteriosclerosis.

High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆

I. Holme, A. Aastveit, G. Walldius, 2002 .

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1984, The American journal of medicine.

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.

M. Eriksson, I. Holme, G. Walldius, 1997, Journal of internal medicine.

Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo Study.

S. Tonstad, I. Holme, L. Håheim, 2008, American journal of epidemiology.

Quality-adjusted meta-analysis of the hypertension/coronary dilemma.

I. Holme, I. Hjermann, L. Ekelund, 1994, American journal of hypertension.

Cholesterol reduction and its impact on coronary artery disease and total mortality.

I. Holme, 1995, The American journal of cardiology.

Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives

S. Anderssen, I. Holme, I. Seljeflot, 2007, Scandinavian cardiovascular journal : SCJ.

Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population.

I. Holme, A. K. Jenum, K. Birkeland, 2014, Paediatric and perinatal epidemiology.

Ethnic Differences in Neonatal Body Composition in a Multi-Ethnic Population and the Impact of Parental Factors: A Population-Based Cohort Study

I. Holme, A. K. Jenum, K. Birkeland, 2013, PloS one.

Two short questionnaires on leisure-time physical activity compared with serum lipids, anthropometric measurements and aerobic power in a suburban population from Oslo, Norway

S. Anderssen, I. Holme, S. Graff-Iversen, 2007, European Journal of Epidemiology.

Risk factors associated with body mass index increase in men at 28 years follow-up.

I. Holme, A. Søgaard, L. Lund Håheim, 2006, QJM : monthly journal of the Association of Physicians.

The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

V. Backer, I. Holme, L. J. Petersen, 2007, Respiratory medicine.

Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial).

O. Faergeman, I. Holme, J. Kastelein, 2010, The American journal of cardiology.

101/2 Year Follow-up of the Multiple Risk Factor Intervention Trial

I. Holme, 2005 .

Extension of clinical trials. 10 1/2 year follow-up of the Multiple Risk Factor Intervention Trial.

I. Holme, 1990, Circulation.

The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam.

I. Holme, H. Weber, E. Amlie, 1993, Spine.

Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years.

P. Nafstad, I. Holme, L. Håheim, 2006, American journal of epidemiology.

years follow up of the Oslo Study . Smoking habits and risk of fatal stroke : 18

I. Holme, I. Hjermann, L. Håheim, 2022 .

Valvular Heart Disease Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

J. Chambers, F. Neumann, I. Holme, 2011 .

Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population

I. Holme, A. Aastveit, N. Hammar, 2012, Annals of medicine.

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial

J. Kastelein, O. Faergeman, I. Holme, 2009, Journal of internal medicine.

Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention

I. Holme, S. Graff-Iversen, A. K. Jenum, 2005, Diabetologia.

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.

D. Wheeler, I. Holme, David Talbot, 2001, Kidney international.

Treatment of Acute Low-back Pain with Piroxicam: Results of a Double-blind Placebo-controlled Trial

I. Holme, H. Weber, E. Amlie, 1987, Spine.

Arterial and venous plasma catecholamines during submaximal steady-state exercise.

I. Holme, H. Refsum, M. Rostrup, 1998, Clinical physiology.

Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials.

I. Holme, 1996, Controlled clinical trials.

CLINICAL/ORIGINAL PAPERS Differences Between Echocardiographic Measurements of Left Ventricular Dimensions and Function by Local Investigators and a Core Laboratory in a 2-year Follow-up Study of Patients with an Acute Myocardial Infarction

I. Holme, G. Frøland, T. Hole, 2002 .

Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction.

I. Holme, T. Skjaerpe, M. G. St. John Sutton, 2002, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

MAPHY and the two arms of HAPPHY.

I. Holme, 1989, JAMA.

MRFIT and the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1983, Journal of the American Medical Association (JAMA).

Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica.

Socio-economic status as a coronary risk factor: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica. Supplementum.

CORONARY RISK FACTORS AND SOCIOECONOMIC STATUS The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1976, The Lancet.

Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study.

S. Tonstad, I. Holme, L. Håheim, 2007, Metabolic syndrome and related disorders.

[Cardiovascular risk factors among 40-year old men and women in Oslo 1981-1999].

S. Tonstad, I. Holme, I. Hjermann, 2004, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

K. W. Davidson, J. Gallacher, J. Danesh, 2012, International journal of epidemiology.

Long-term survival in pre-specified groups at risk in the Oslo Study, 1972–1973

I. Holme, 2015, Scandinavian journal of public health.

Co-variation of alanine aminotransferase levels with relative weight in blood donors.

I. Holme, G. Hetland, J. Strømme, 1992, Scandinavian journal of clinical and laboratory investigation.

The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials

G. L’italien, I. Holme, J. Snyder, 2013, Transplantation.

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.

W. März, I. Holme, A. Jardine, 2010, Kidney international.

Cerebrovascular Events in Renal Transplant Recipients

I. Holme, A. Jardine, B. Maes, 2009, Transplantation.

Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study

F. Zannad, I. Holme, R. Schmieder, 2012, Journal of internal medicine.

Lifelong benefits on myocardial infarction mortality: 40‐year follow‐up of the randomized Oslo diet and antismoking study

I. Holme, I. Hjermann, K. Retterstøl, 2016, Journal of internal medicine.

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

I. Holme, A. Hartmann, A. Jardine, 2003, The Lancet.

Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.

I. Holme, A. Hartmann, A. Jardine, 2004, Kidney international.

Risk Factors and Raised Atherosclerotic Lesions in Coronary and Cerebral Arteries

L. Solberg, J. Strong, I. Holme, 1981, Arteriosclerosis.

Smoking and Atherosclerotic Disease. The Oslo Study

L. Solberg, I. Holme, I. Hjermann, 1983 .

Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure.

I. Holme, H. Waaler, 2009, Acta medica Scandinavica.

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

I. Holme, I. Hjermann, S. Enger, 1979, Artery.

Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial.

S. Tonstad, I. Holme, P. Tønnesen, 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction.

T. Strandberg, O. Faergeman, I. Holme, 2009, The American journal of cardiology.

High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study.

I. Holme, G. Walldius, I. Jungner, 1992, Blood pressure. Supplement.

Effect of long-term changes in diet and exercise on plasma leptin concentrations.

C. Drevon, J. Reseland, S. Anderssen, 2001, The American journal of clinical nutrition.

Effect of long-term changes in diet and exercise on plasma leptin concentrations 1 – 3

C. Drevon, J. Reseland, S. Anderssen, 2022 .

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

I. Holme, I. Hjermann, S. Enger, 1978, British medical journal.

Antihypertensive drugs and blood lipids: the Oslo study.

I. Holme, I. Hjermann, S. Kjeldsen, 1982, British journal of clinical pharmacology.

Possible metabolic side effects of beta-adrenergic blocking drugs.

I. Holme, I. Hjermann, A. Helgeland, 1978, British medical journal.

Antihypertensive Drugs and Blood Lipids: The Oslo Study

I. Holme, I. Hjermann, S. Kjeldsen, 1982, Journal of cardiovascular pharmacology.

[Piroxicam and naproxen in arthrosis. A double-blind, comparative multicenter study in general practice].

I. Holme, K. Giercksky, G. Husby, 1986, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: Relation to age, sex, efficacy and adverse events

I. Holme, K. Giercksky, Ø. Hundal, 1986, Clinical Rheumatology.

Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, European journal of heart failure.

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1978, The American journal of medicine.

Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.

I. Holme, I. Hjermann, H. Arnesen, 1998, Journal of cardiovascular pharmacology.

Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience.

I. Holme, P. Fauchald, H. P. Stokke, 1991, American heart journal.

Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals.

I. Holme, I. Hjermann, D. Nilsen, 2009, Acta medica Scandinavica.

The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women.

J. Medbø, J. Hallén, I. Holme, 1996, British journal of clinical pharmacology.

Treatment of Borderline and Mild Hypertension: The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1981 .

Cholesterol reduction in single and multifactor randomized trials: relationship to CHD incidence and total mortality as found by meta analysis of twenty-two trials.

I. Holme, 1992, Blood pressure. Supplement.

Seasonal variations of pigmented naevi. Intercorrelations of clinical and histological variables with special reference to seasonal variation.

I. Holme, T. E. Larsen, S. Mogensen, 1990, Acta dermato-venereologica.

Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.

I. Holme, T. Skjaerpe, M. G. St. John Sutton, 2002, European heart journal.

Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo Study

I. Holme, I. Hjermann, L. Håheim, 1995, Journal of hypertension.

Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).

T. Strandberg, O. Faergeman, I. Holme, 2009, Atherosclerosis.

Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study

O. Faergeman, I. Holme, J. Kastelein, 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Exercise-induced increase in lipoprotein (a).

S. Anderssen, I. Holme, P. Urdal, 1996, Atherosclerosis.

Dystonia and dyskinesia in glutaric aciduria type I: Clinical heterogeneity and therapeutic considerations

E. Jellum, I. Holme, M. Kyllerman, 1994, Movement disorders : official journal of the Movement Disorder Society.

I. Holme, T. Skjaerpe, M. G. St. John Sutton, 2002, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Response to Letters Regarding Article, “Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction”

F. Neumann, I. Holme, C. Nienaber, 2011 .

Oslo Study Diet and Antismoking Trial. Results after 102 months.

I. Holme, I. Hjermann, P. Leren, 1986, The American journal of medicine.

Inﬂammation-associated graft loss in renal transplant recipients

W. März, I. Holme, H. Scharnagl, 2011 .

Tu-W20:4 Apolipoprotein B/A1 ratio is a better discriminator of risk of coronary heart disease than is LDL/HDL cholesterol ratio in the ideal study

I. Holme, A. Olsson, T. Pedersen, 2006 .

The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica.

Reproducibility of Quantitative Arteriographic Assessment of Atherosclerosis in the Femoral Artery

S. Nilsson, I. Holme, G. Walldius, 1993, Acta radiologica.

Cholesterol Reduction and Total Mortality Recently in Circulation

I. Holme, 2005 .

On the separation of the intervention effects of diet and antismoking advice on the incidence of major coronary events in coronary high risk men. The Oslo Study.

I. Holme, 1982, Journal of the Oslo city hospitals.

Increased Predictive Ability of BMI but not Other Risk Factors with Time in Men: 39-Year Follow-Up of Total Mortality in the Oslo Study

S. Tonstad, I. Holme, 2014, Obesity Facts.

[The Oslo study. 4-year mortality, coronary risk factors and socioeonomic indicators].

I. Holme, I. Hjermann, A. Helgeland, 1980, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

ApoB but not LDL‐cholesterol is reduced by exercise training in overweight healthy men. Results from the 1‐year randomized Oslo Diet and Exercise Study

S. Anderssen, I. Holme, A. Høstmark, 2007, Journal of internal medicine.

Cholesterol Reduction and Total Mortality

I. Holme, 1991 .

CORONARY RISK FACTORS AND SOCIOECONOMIC STATUS

I. Holme, Richard Rothenberg, 1977, The Lancet.

Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.

I. Holme, S. Kjeldsen, 2015, European journal of internal medicine.

Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.

I. Holme, I. Hjermann, A. Helgeland, 1984, JAMA.

DHA reduces oxidative stress following hypoxia-ischemia in newborn piglets: a study of lipid peroxidation products in urine and plasma

I. Holme, M. Vento, O. Saugstad, 2018, Journal of perinatal medicine.

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

O. Faergeman, I. Holme, J. Kastelein, 2005, JAMA.

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to identify the lipoprotein‐related risk of vascular disease

I. Holme, A. Aastveit, G. Walldius, 2006, Journal of internal medicine.

Comparing Cardiorespiratory Fitness Across Populations: Response

S. Anderssen, I. Holme, S. Dyrstad, 2014 .

The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries: Response

T. Krosshaug, L. Engebretsen, R. Bahr, 2016, The American journal of sports medicine.

Effects of a three-year intervention: the Copenhagen School Child Intervention Study.

L. Andersen, K. Froberg, I. Holme, 2012, Medicine and science in sports and exercise.

Association between the blood pressure response to a change in posture and the 6-year incidence of hypertension: prospective findings from the ARIC study

A. Sharrett, G. Heiss, I. Holme, 2002, Journal of Human Hypertension.

Urban air pollution and mortality in a cohort of Norwegian men.

B. Oftedal, P. Nafstad, I. Holme, 2004, Environmental health perspectives.

A randomized, multicentre, double‐blind, parallel‐group study to assess the adverse event‐related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis

B. Ringertz, I. Holme, L. Dahlberg, 2009, Scandinavian journal of rheumatology.

Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study.

I. Holme, I. Hjermann, A. Helgeland, 1988, American journal of epidemiology.

Long-term risks for kidney donors.

F. Dekker, I. Holme, A. Hartmann, 2014, Kidney international.

[Treatment with statins: further data from the Heart Protection Study].

S. Tonstad, I. Holme, 2002, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men

I. Holme, I. Hjermann, P. Leren, 1981, The Lancet.

Prevention of Injuries among Male Soccer Players

Lars Engebretsen, Roald Bahr, L. Engebretsen, 2008, The American journal of sports medicine.

Physical fitness, injuries, and team performance in soccer.

Lars Engebretsen, Roald Bahr, L. Engebretsen, 2004, Medicine and science in sports and exercise.

Intrinsic Risk Factors for Hamstring Injuries Among Male Soccer Players

Lars Engebretsen, Roald Bahr, L. Engebretsen, 2010, The American journal of sports medicine.

Intrinsic Risk Factors for Groin Injuries among Male Soccer Players

Lars Engebretsen, Roald Bahr, L. Engebretsen, 2010, The American journal of sports medicine.

The Effect of Anesthesia on Intraoperative and Postoperative Bleeding during Abdominal Prostatectomies: A Comparison of Neurolept Anesthesia, Halothane Anesthesia and Epidural Anesthesia

I. Holme, I. Lund, T. Thorud, 1975 .

One‐ and five‐year follow‐ups on blood pressure and renal function in kidney donors

I. Holme, P. Fauchald, H. Holdaas, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries in Female Elite Soccer and Handball Players

Lars Engebretsen, Tron Krosshaug, Roald Bahr, 2016, The American journal of sports medicine.

Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.

S. Grundy, D. Waters, O. Faergeman, 2009, The American journal of cardiology.

Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations.

S. Tonstad, I. Holme, B. Kirkhus, 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: A randomized, controlled study

M. Svendsen, S. Tonstad, I. Holme, 2015, Blood pressure.

Cartilage repair in the rabbit knee: mosaic plasty resulted in higher degree of tissue filling but affected subchondral bone more than microfracture technique

L. Engebretsen, I. Holme, F. Reinholt, 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women

I. Holme, K. Bø, T. Talseth, 1999, BMJ.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Markus Abt, Jean-Claude Tardif, Eran Leitersdorf, 2012, The New England journal of medicine.

Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)

O. Faergeman, I. Holme, J. Kastelein, 2008, Annals of medicine.

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

Anders G. Olsson, Prakash Deedwania, Michael Gaffney, 2008, Circulation.

Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study

I. Holme, S. Berntsen, A. K. Jenum, 2011, European journal of endocrinology.

A double‐blind, placebo‐controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

I. Holme, L. Elsborg, H. Nyhlin, 2004, Scandinavian journal of gastroenterology.

Quantitation of atherosclerosis in femoral arteriography with ECG gated exposures.

A Hemmingsson, S. Nilsson, I. Holme, 1988, Acta radiologica.

Self-Reported Injury History and Lower Limb Function as Risk Factors for Injuries in Female Youth Soccer

R. Bahr, I. Holme, T. E. Andersen, 2008, The American journal of sports medicine.

Intrinsic risk factors for acute ankle injuries among male soccer players: a prospective cohort study

L. Engebretsen, R. Bahr, I. Holme, 2009, Scandinavian journal of medicine & science in sports.

Risk Factors for Injuries in Football

Lars Engebretsen, Roald Bahr, L. Engebretsen, 2004, The American journal of sports medicine.

Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients

W. März, I. Holme, S. Pilz, 2014, Transplantation.

Risk Factors for Lower Extremity Injuries in Elite Female Soccer Players

Roald Bahr, Thor Einar Andersen, R. Bahr, 2014, The American journal of sports medicine.

Comprehensive warm-up programme to prevent injuries in young female footballers: cluster randomised controlled trial

Jiri Dvorak, Mario Bizzini, Roald Bahr, 2008, BMJ : British Medical Journal.

The effect of anesthesia on intraoperative and postoperative bleeding during abdominal prostatectomies: a comparison of neurolept anesthesia, halothane anesthesia and epidural anesthesia.

I. Holme, I. Lund, T. Thorud, 1976, Acta anaesthesiologica Scandinavica. Supplementum.

Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women

I. Holme, A. K. Jenum, K. Birkeland, 2012, BMC Public Health.

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

Curt D. Furberg, Are H. Aastveit, C. Furberg, 2004, Clinical chemistry and laboratory medicine.

The effect of warfarin on mortality and reinfarction after myocardial infarction.

P Smith, I. Holme, H. Arnesen, 1990, The New England journal of medicine.

Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men

B. Oftedal, P. Nafstad, I. Holme, 2003, Thorax.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Jean-Claude Tardif, Eran Leitersdorf, Lawrence A Leiter, 2009, American heart journal.

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

I. Holme, A. Aastveit, G. Walldius, 2001, The Lancet.

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

Christina Lindahl, Nicholas J Wareham, Mogens Lytken Larsen, 2008, Journal of the American College of Cardiology.

The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.

I. Holme, R. Upmanyu, M. V. van Hessen, 2014, European heart journal.

Increases in physical activity is as important as smoking cessation for reduction in total mortality in elderly men: 12 years of follow-up of the Oslo II study

S. Anderssen, I. Holme, 2015, British Journal of Sports Medicine.

Rosuvastatin‐Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study

Inge Christoffer Olsen, G. Kitas, I. Holme, 2015, Arthritis & Rheumatology.

Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and Antismoking Study after its close.

S. Tonstad, I. Holme, I. Hjermann, 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.

I. Holme, Ingar Holme, 1990, Circulation.

Preventing eating disorders among young elite athletes: a randomized controlled trial.

R. Bahr, I. Holme, J. Sundgot-Borgen, 2014, Medicine and science in sports and exercise.

Incidence of hypertrophic cardiomyopathy in hypothyroidism.

I. Holme, E. Haug, G. Smith, 1995, Thyroid : official journal of the American Thyroid Association.

Combined diet and exercise intervention reverses the metabolic syndrome in middle‐aged males: results from the Oslo Diet and Exercise Study

S. Anderssen, I. Holme, P. Urdal, 2007, Scandinavian journal of medicine & science in sports.

Intervention Effects on Physical Activity and Insulin Levels in Men of Pakistani Origin Living in Oslo: A Randomised Controlled Trial

S. Anderssen, I. Holme, E. Andersen, 2012, Journal of Immigrant and Minority Health.

Risk factors for sports injuries — a methodological approach

R Bahr, R. Bahr, I. Holme, 2003, British journal of sports medicine.

Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With Hyperparathyroidism

W. März, I. Holme, S. Pilz, 2015, Transplantation.

Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway

A. Engeland, S. Anderssen, I. Holme, 2008, Scandinavian journal of medicine & science in sports.

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study group

R. Hatlevoll, A. Brun, I. Holme, 1981, Cancer.

The Oslo study. Cardiovascular disease in middle-aged and young Oslo men.

I. Holme, I. Hjermann, A. Helgeland, 1975, Acta medica Scandinavica. Supplementum.

Reference values for cardiorespiratory response and fitness on the treadmill in a 20- to 85-year-old population.

S. Anderssen, I. Holme, S. Dyrstad, 2013, Chest.

The development of the brief eating disorder in athletes questionnaire.

I. Holme, M. K. Torstveit, J. Sundgot-Borgen, 2014, Medicine and science in sports and exercise.

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

I. Holme, A. Aastveit, N. Hammar, 2010, Atherosclerosis.

Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study)

I. Holme, C. Gohlke-Bärwolf, J. Chambers, 2010 .

Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).

O. Faergeman, I. Holme, J. Kastelein, 2009, The American journal of cardiology.

Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

I. Holme, C. Nienaber, T. Skjaerpe, 2007, The American journal of cardiology.

Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study

I. Holme, A. Jardine, P. Fauchald, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, American journal of epidemiology.

Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study.

L. Weissfeld, O. Williams, L. Solberg, 1985, The American journal of cardiology.

Sex-specific relevance of diabetes to occlusive vascular and other mortality : a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

R. Collins, D. Levy, E. Rimm, 2019 .

Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function.

I. Holme, M. G. St. John Sutton, M St John Sutton, 1997, European heart journal.

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

I. Holme, G. Walldius, S. Marcovina, 1998, Clinical chemistry.

A Cardiovascular Risk Calculator for Renal Transplant Recipients

I. Holme, A. Jardine, K. Budde, 2012, Transplantation.

Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES).

S. Anderssen, I. Holme, P. Urdal, 1995, Blood pressure.

The built environment correlates of objectively measured physical activity in Norwegian adults: A cross-sectional study

S. Anderssen, I. Holme, E. Kolle, 2017, Journal of sport and health science.

Long-Term Correlates of Objectively Measured Physical Activity and Sedentary Time in Norwegian Men and Women.

U. Ekelund, S. Anderssen, I. Holme, 2015, Journal of physical activity & health.

Promoting physical activity in a multi-ethnic district - methods and baseline results of a pseudo-experimental intervention study

R. Bahr, S. Anderssen, I. Holme, 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Association of cardiac autonomic function and the development of hypertension: the ARIC study.

J. Cai, G. Heiss, I. Holme, 1996, American journal of hypertension.

High-intensity training following lung cancer surgery: a randomised controlled trial

S. Anderssen, I. Holme, L. Nordsletten, 2014, Thorax.

Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the ‘atherothrombogenic syndrome’. Oslo Diet and Exercise Study (ODES). A randomized trial

S. Anderssen, I. Holme, P. Urdal, 1996, Journal of internal medicine.

6-year follow-up of 84 patients with cartilage defects in the knee

L. Engebretsen, I. Holme, S. Heir, 2010, Acta orthopaedica.

Cholesterol lowering and the reduction of CHD incidence and total mortality: Results from a meta-analysis of randomized trials

I. Holme, 1992, Cardiovascular Drugs and Therapy.

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid‐lowering in primary care

M. Eriksson, I. Holme, G. Walldius, 1998 .

Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

J. Chambers, F. Neumann, I. Holme, 2011, Circulation.

The effect of exercise and diet on mental health and quality of life in middle-aged individuals with elevated risk factors for cardiovascular disease.

H. Ursin, S. Anderssen, I. Holme, 1999, Journal of sports sciences.

Promoting Physical Activity in a Low-Income Multiethnic District: Effects of a Community Intervention Study to Reduce Risk Factors for Type 2 Diabetes and Cardiovascular Disease

R. Bahr, S. Anderssen, I. Holme, 2006, Diabetes Care.

Effects of a 2‐year school‐based daily physical activity intervention on cardiovascular disease risk factors: the Sogndal school‐intervention study

L. Andersen, S. Anderssen, I. Holme, 2011, Scandinavian journal of medicine & science in sports.

Benefit of a stroke unit: a randomized controlled trial.

I. Holme, B. Indredavik, F. Bakke, 1991, Stroke.

Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort

S. Tonstad, I. Holme, 2013, European journal of preventive cardiology.

Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.

W. März, C. Wanner, I. Holme, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Patterns of Objectively Measured Physical Activity in Normal Weight, Overweight, and Obese Individuals (20–85 Years): A Cross-Sectional Study

S. Anderssen, I. Holme, E. Kolle, 2013, PloS one.

Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases

Inge Christoffer Olsen, I. Holme, J. Hisdal, 2014 .

Lifestyle Changes May Reverse Development of the Insulin Resistance Syndrome. The Oslo Diet and Exercise Study: a randomized trial

S. Anderssen, I. Holme, P. Urdal, 1997, Diabetes Care.

An adapted version of the long International Physical Activity Questionnaire (IPAQ-L): construct validity in a low-income, multiethnic population study from Oslo, Norway

S. Anderssen, I. Holme, S. Graff-Iversen, 2007, The international journal of behavioral nutrition and physical activity.

Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic

I. Holme, A. Semb, T. Kvien, 2012, Annals of the rheumatic diseases.

Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).

J. Chambers, I. Holme, C. Nienaber, 2010, The American journal of cardiology.

Determinants of Cardiovascular Risk in Haemodialysis Patients: Post hoc Analyses of the AURORA Study

F. Zannad, I. Holme, R. Schmieder, 2013, American Journal of Nephrology.

Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome.

S. Tonstad, I. Holme, T. Pedersen, 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Rosuvastatin in diabetic hemodialysis patients.

F. Zannad, I. Holme, R. Schmieder, 2011, Journal of the American Society of Nephrology : JASN.

Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial.

Christina Lindahl, Mogens Lytken Larsen, Terje R Pedersen, 2009, Journal of the American College of Cardiology.

Inflammation in renal transplantation.

W. März, I. Holme, A. Jardine, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels.

O. Faergeman, I. Holme, J. Kastelein, 2013, International journal of cardiology.

Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, Scandinavian journal of clinical and laboratory investigation.

The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia

S. Nilsson, I. Holme, G. Walldius, 1994, Journal of internal medicine.

Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).

L. Goldman, I. Holme, D. Julian, 1999, Anesthesiology.

Physical activity and cardiovascular risk factors in a 40- to 42-year-old rural Norwegian population from 1975–2010: repeated cross-sectional surveys

S. Anderssen, I. Holme, S. Graff-Iversen, 2014, BMC Public Health.

Exercise and diet interventions improve perceptions of self in middle‐aged adults

H. Ursin, S. Anderssen, I. Holme, 1997, Scandinavian journal of medicine & science in sports.

Effects of physical activity on schoolchildren's academic performance: The Active Smarter Kids (ASK) cluster-randomized controlled trial.

U. Ekelund, L. Andersen, S. Anderssen, 2016, Preventive medicine.

Four-year mortality by some socioeconomic indicators: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, Journal of epidemiology and community health.

Coronary risk factors in various occupational groups: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1977, British journal of preventive & social medicine.

Prevention of hamstring strains in elite soccer: an intervention study

L Engebretsen, R Bahr, L. Engebretsen, 2007, Scandinavian journal of medicine & science in sports.

Objectively Measured Physical Activity in Home Guard Soldiers During Military Service and Civilian Life.

S. Anderssen, I. Holme, R. Hageberg, 2016, Military medicine.

Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients.

I. Holme, A. Jardine, H. Holdaas, 2010, Atherosclerosis.

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting

I. Holme, S. Kjeldsen, J. Sundström, 2015, Clinical Drug Investigation.

Validity and reliability of bioelectrical impedance analysis and skinfold thickness in predicting body fat in military personnel.

S. Anderssen, I. Holme, R. Hageberg, 2014, Military medicine.

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

I. Holme, A. Aastveit, N. Hammar, 2009, Journal of internal medicine.

The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders

M. Svendsen, S. Tonstad, I. Holme, 2007, European Journal of Clinical Nutrition.

Associations between type A behaviour pattern and psychological distress

O. Dalgard, I. Holme, E. Røysamb, 2008, Social Psychiatry and Psychiatric Epidemiology.

Compliance with a comprehensive warm-up programme to prevent injuries in youth football

Jiri Dvorak, Roald Bahr, Thor Einar Andersen, 2010, British Journal of Sports Medicine.

Knee scores improved but recovery was incomplete

L. Engebretsen, I. Holme, S. Heir, 2010 .

Stress reactivity to and recovery from a standardised exercise bout: a study of 31 runners practising relaxation techniques

I. Holme, A. Holen, J. Sundgot-Borgen, 2000, British Journal of Sports Medicine.

Intrinsic risk factors for acute knee injuries among male football players: a prospective cohort study

L. Engebretsen, R. Bahr, I. Holme, 2011, Scandinavian journal of medicine & science in sports.

Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations.

S. Tonstad, I. Holme, F. Haugen, 2012, Metabolic syndrome and related disorders.

Psychosocial correlates of stages of change in physical activity in an adult community sample

I. Holme, Y. Ommundsen, C. Lorentzen, 2007 .

The "Romsås in Motion" community intervention: program exposure and psychosocial mediated relationships to change in stages of change in physical activity

I. Holme, A. K. Jenum, Y. Ommundsen, 2007, The international journal of behavioral nutrition and physical activity.

A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study.

I. Holme, K. Tveter, S. Sander, 1990, Scandinavian journal of urology and nephrology.

Effects of Match Location on Playing Tactics for Goal Scoring in Norwegian Professional Soccer

R. Bahr, I. Holme, A. Tenga, 2010 .

Preventing injuries in female youth football – a cluster‐randomized controlled trial

R. Bahr, I. Holme, O. Olsen, 2008, Scandinavian Journal of Medicine & Science in Sports.

Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study

I. Holme, L. Nordsletten, H. Kvernmo, 2013, The Journal of hand surgery, European volume.

Level of physical activity, cardiorespiratory fitness and cardiovascular disease risk factors in a rural adult population in Sogn og Fjordane

S. Anderssen, I. Holme, A. Mamen, 2011 .

Apolipoproteins and prediction of fatal myocardial infarction

I. Holme, A. Aastveit, G. Walldius, 2002, The Lancet.

[Changes in cardiovascular risk factors among men in Oslo during 28 years].

I. Holme, L. Håheim, A. Søgaard, 2006, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Trends in the incidence of acute myocardial infarction and stroke: a 21‐year follow‐up of the Oslo study

S. Tonstad, I. Holme, I. Hjermann, 2004, Scandinavian cardiovascular journal : SCJ.

[Coronary risk factors and socioeconomic status. The Oslo study].

I. Holme, I. Hjermann, A. Helgeland, 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Anthropometrics, Body Composition, And Aerobic Fitness in Norwegian Home Guard Personnel

S. Anderssen, I. Holme, R. Hageberg, 2014, Journal of strength and conditioning research.

The association between blood pressure and serum cholesterol in healthy men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1978, Journal of epidemiology and community health.

The “Romsås in Motion” Community Intervention: Mediating Effects of Psychosocial Factors on Forward Transition in the Stages of Change in Physical Activity

I. Holme, A. K. Jenum, Y. Ommundsen, 2009, Health education & behavior : the official publication of the Society for Public Health Education.

Effects of Fluvastatin on Cardiac Events in Renal Transplant Patients: ALERT (Assessment of Lescol® in Renal Transplantation) Study Design and Baseline Data

I. Holme, A. Hartmann, A. Jardine, 2001, Journal of cardiovascular risk.

Validity and reliability of the 20 meter shuttle run test in military personnel.

S. Anderssen, I. Holme, S. Berntsen, 2011, Military medicine.

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

I. Holme, T. T. Haug, S. Blomhoff, 2001, British Journal of Psychiatry.

Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study

S. Tonstad, I. Holme, L. Håheim, 1997, Environmental health perspectives.

Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study.

L. Solberg, J. Strong, I. Holme, 1985, Laboratory investigation; a journal of technical methods and pathology.

Exposure therapy and sertraline in social phobia: Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial 1-year follow-up of a randomised controlled trial

I. Holme, T. T. Haug, S. Blomhoff, 2003 .

Helmet use and risk of head injuries in alpine skiers and snowboarders: changes after an interval of one decade

R. Bahr, I. Holme, A. Ekeland, 2016, British Journal of Sports Medicine.

Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention

I. Holme, J. Hisdal, A. Semb, 2014, Annals of the rheumatic diseases.

[Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73].

S. Tonstad, I. Holme, 2011, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: A 21-year prospective cohort study

S. Tonstad, I. Holme, I. Hjermann, 2007, Scandinavian journal of public health.

Tegaserod is an effective and safe therapy for irritable bowel syndrome in a nordic population

I. Holme, L. Elsborg, H. Nyhlin, 2003 .

Validity of the ActiGraph GT1M during walking and cycling

S. Anderssen, I. Holme, E. Kolle, 2014, Journal of sports sciences.

[Physical activity, smoking and mortality among men who participated in the Oslo studies of 1972 and 2000].

S. Anderssen, I. Holme, 2014, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Monday and non‐Monday concentrations of lifestyle‐related blood components in the Oslo Diet and Exercise Study

S. Anderssen, I. Holme, P. Urdal, 1998, Journal of internal medicine.

A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis

I. Holme, K. Giercksky, G. Husby, 2005, Clinical Rheumatology.

Effect of cimetidine on gastrointestinal symptoms in patients taking nonsteroidal anti-inflammatory drugs. A large double-blind placebo controlled study.

I. Holme, K. Giercksky, H. Rugstad, 1994, Scandinavian Journal of Rheumatology.

A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis

Terje R Pedersen, Kenneth Egstrup, William Malbecq, 2011, Heart.

Objectively recorded physical activity and the association with gestational diabetes

I. Holme, S. Berntsen, A. K. Jenum, 2014, Scandinavian journal of medicine & science in sports.

Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study.

I. Holme, I. Hjermann, L. Håheim, 1995, Stroke.

approachfactors for sports injuries — a methodological

R. Bahr, I. Holme, 2005 .

Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study.

I. Holme, 1982, Journal of the Oslo city hospitals.

Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients.

I. Holme, A. Hartmann, A. Jardine, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Relation of number of different responses to group size and stimulus words in a discrete free‐association situation

I. Holme, E. Mohn, Kjell Flekkø, 1973 .

Clinical and histological intercorrelations in pigmented naevi indicating potential melanoma precursor lesions

I. Holme, T. E. Larsen, S. Mogensen, 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

programme to prevent injuries in youth football Compliance with a comprehensive warm-up

R. Bahr, I. Holme, T. Soligard, 2010 .

A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes – a randomized controlled trial

I. Holme, K. Hvaal, B. Kilhovd, 2015, BMC Endocrine Disorders.

Relationship between floor type and risk of ACL injury in team handball

L. Engebretsen, R. Bahr, I. Holme, 2003, Scandinavian journal of medicine & science in sports.

Piroxicam and naproxen in patients with osteoarthritis of the hip waiting for total hip replacement

I. Holme, A. Alho, Ø. Jaer, 1988, Clinical Rheumatology.

Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

R. Collins, R. Kronmal, E. Vartiainen, 2018, The lancet. Diabetes & endocrinology.

Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study

I. Holme, S. Berntsen, A. K. Jenum, 2012, European Journal of Endocrinology.

Improving cardiovascular disease prevention : from risk assessment to novel therapy

S. Grundy, P. Barter, J. Kastelein, 2009 .

The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).

S. Nilsson, I. Holme, G. Walldius, 1994, The American journal of cardiology.

Adjusting parameters of aortic valve stenosis severity by body size

J. Chambers, F. Neumann, I. Holme, 2014, Heart.

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

J. Chambers, I. Holme, C. Nienaber, 2008, The New England journal of medicine.

The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

I. Holme, N. Jørgensen, B. M. Henriksen, 2006, Respiratory medicine.

Association between Risk Factors and Atherosclerotic Lesions Based on Autopsy Findings in the Oslo Study: A Preliminary Report

L. Solberg, J. Strong, I. Holme, 1977 .

Effects of lipid-lowering therapy on total and coronary mortality.

I. Holme, 1995, Current opinion in lipidology.

Quantitation of Atherosclerosis in Femoral Arteriography with Ecg Gated Exposures

S. Nilsson, I. Holme, G. Walldius, 1988 .

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

J. Gallacher, J. Danesh, E. Rimm, 2012, International journal of epidemiology.

Preventing injuries in female youth football – a cluster‐randomized controlled trial

R. Bahr, I. Holme, O. Olsen, 2008, Scandinavian journal of medicine & science in sports.

Exercises to prevent lower limb injuries in youth sports: cluster randomised controlled trial

L. Engebretsen, R. Bahr, I. Holme, 2005, BMJ : British Medical Journal.

A Cardiovascular Risk Calculator for Renal Transplant Recipients

I. Holme, A. Jardine, K. Budde, 2012, Transplantation.

Long-term survival in pre-specified groups at risk in the Oslo Study, 1972–1973

I. Holme, 2015, Scandinavian journal of public health.

Effects of a three-year intervention: the Copenhagen School Child Intervention Study.

L. Andersen, K. Froberg, I. Holme, 2012, Medicine & Science in Sports & Exercise.

Validity of the ActiGraph GT1M during walking and cycling

S. Anderssen, I. Holme, E. Kolle, 2014, Journal of sports sciences.

International Journal of Behavioral Nutrition and Physical Activity the "romsås in Motion" Community Intervention: Program Exposure and Psychosocial Mediated Relationships to Change in Stages of Change in Physical Activity

I. Holme, A. K. Jenum, Y. Ommundsen, 2006 .

Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic

I. Holme, A. Semb, T. Kvien, 2012, Annals of the rheumatic diseases.

LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study

The Oslo study: CHD risk factors, socioeconomic influences, and intervention.

I. Holme, I. Hjermann, A. Helgeland, 1983, American heart journal.